Raia Drogasil (BSP:RADL3) Ending Cash Position: R$537 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:RADL3 Raia Drogasil SA BSP:RADL3
94 GF Score
Price R$18.30
GF Value R$26.90
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Raia Drogasil Ending Cash Position?

Raia Drogasil BSP:RADL3 +1.67% 94 Ending Cash Position is R$537 Mil as of Jun. 2026. GuruFocus rates BSP:RADL3 with a GF Score™ of 94/100 and a GF Value™ of R$26.90 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Raia Drogasil's Ending Cash Position for the quarter that ended in Jun. 2026 was R$537 Mil.

Raia Drogasil's quarterly Ending Cash Position declined from Dec. 2025 (R$510 Mil) to Mar. 2026 (R$442 Mil) but then increased from Mar. 2026 (R$442 Mil) to Jun. 2026 (R$537 Mil).

Raia Drogasil's annual Ending Cash Position increased from Dec. 2023 (R$412 Mil) to Dec. 2024 (R$528 Mil) but then declined from Dec. 2024 (R$528 Mil) to Dec. 2025 (R$510 Mil).

Raia Drogasil Ending Cash Position Related Terms

Raia Drogasil Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Raia Drogasil's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raia Drogasil Ending Cash Position Chart

Raia Drogasil Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 356.12 433.54 412.32 528.00 509.62

Raia Drogasil Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 527.02 436.34 509.62 441.80 536.50
BSP:RADL3
94GF Score
Raia Drogasil SA BSP:RADL3
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raia Drogasil Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Raia Drogasil's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=528.002+-18.383
=510

Raia Drogasil's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=441.802+94.699
=537

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of R$537 Mil mean?
Raia Drogasil (BSP:RADL3) has a Ending Cash Position of R$537 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Raia Drogasil and its competitors.
Is Raia Drogasil's Ending Cash Position too high?
Raia Drogasil's current Ending Cash Position is R$537 Mil. Overall, Raia Drogasil has a GF Score™ of 94/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raia Drogasil's Ending Cash Position compare to competitors?
Raia Drogasil's Ending Cash Position of R$537 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Raia Drogasil and its competitors. Raia Drogasil's current Ending Cash Position is R$537 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raia Drogasil stock overvalued right now?
Based on GuruFocus' analysis, Raia Drogasil (BSP:RADL3) is currently considered Significantly Undervalued. The stock's GF Value™ is R$26.90, compared to a current price of R$18.30 — trading 32% below its estimated fair value. The current Ending Cash Position is R$537 Mil. Raia Drogasil's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Raia Drogasil (BSP:RADL3), the current Ending Cash Position is R$537 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raia Drogasil (BSP:RADL3) Overvalued in 2026?

Based on GuruFocus' analysis, Raia Drogasil stock appears to be undervalued. The current stock price of R$18.30 is trading 32% below its estimated GF Value™ of R$26.90. GuruFocus considers Raia Drogasil to be Significantly Undervalued.

Key valuation signals for BSP:RADL3:

  • Ending Cash Position: R$537 Mil
  • GF Value™: R$26.90 vs. price of R$18.30 (32% below fair value)
  • GF Score™: 94/100 with 2 warning signs

No single metric tells the full story. See the BSP:RADL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Raia Drogasil Business Description

Other Exchanges RADLY:USA
Address Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-900
Raia Drogasil SA operates a chain of pharmacies in Brazil. The company is mainly engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its pharmacies mainly operate under the Drogasil and Raia brands.
94GF Score

Get the complete analysis for BSP:RADL3

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$18.30
Price
R$26.90
GF Value